Designs and commercializes advanced fully automated molecular pathology workstations for cancer diagnosis, prognosis and personalized medicine. Provides an integrated eFISHency FISH workflow and a miRNA system for characterizing cancers of unknown primary and undifferentiated tumors, serving FISH labs, research institutions, hospitals and pharma/biotech.